Central Nervous System (CNS) therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Global CNS Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029By Global Info Research "...... ain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson's disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact ne......" | 16-Jan-2023 | $3480 | |
Global CNS Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028By QYResearch Group "...... ation and industry data. Data were collected from the CNS Therapeutics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases......" | 13-Oct-2022 | $5600 | |
Global Central Nervous System Disorders Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028By Global Info Research "...... mization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due ......" | 05-Oct-2022 | $3480 | |
Global CNS Therapeutics Market Research Report 2022 - Market Size, Current Insights and Development TrendsBy Maia Research "...... n or multiple factors.
The report focuses on the CNS Therapeutics market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the repor......" | 04-Oct-2022 | $3450 | |
Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ew of the Parkinson's Disease (Central Nervous System) pipeline landscape.
Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of dopaminer......" | 30-Sep-2022 | $2500 | |
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... , provides an overview of the Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline landscape.
Amyotrophic lateral sclerosis (ALS) is the most common degenerative disease of the motor neuron system. The disorder is named for it......" | 30-Sep-2022 | $2500 | |
Insomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ntral Nervous System) pipeline landscape.
Insomnia is a sleep disorder that is characterized by difficulty falling and/or staying asleep. Symptoms include difficulty falling asleep at night, irritability, depression or anxiety, tension h......" | 30-Sep-2022 | $2000 | |
Cancer Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... Pain (Central Nervous System) pipeline landscape.
Cancer pain can be defined as a complex sensation that reflects both damage to the body and the body's response to the damage. Pain may arise due to tumor compressing or infiltrating tis......" | 30-Sep-2022 | $2000 | |
Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ntral Nervous System) pipeline landscape.
Migraine is a disorder characterized by repeated attacks of severe headache. A migraine headache causes throbbing or pulsating pain, usually on only one side of the head. These headaches are ofte......" | 30-Sep-2022 | $2000 | |
Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... hizophrenia (Central Nervous System) pipeline landscape.
Schizophrenia is a chronic, severe, and disabling brain disorder that generally appears in late adolescence or early adulthood. Symptoms include delusions, hallucinations, disorgan......" | 30-Sep-2022 | $2500 | |
|